All In Biotech

Drug Trial Radar · NCT07101965

Phase I Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RSS0343 Tablets in Healthy Subjects After Single and Multiple Oral Administration and the Effect of Food on the Pharmacokinetics of RSS0343

Last checked: Nov 19, 2026Latest source record: Aug 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

72

Actual

Start

Apr 7, 2024

Primary completion

Nov 6, 2024

Study completion Nov 6, 2024

Sponsor

Sponsor type
Industry
First posted
Aug 3, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To evaluate the safety and tolerability of RSS0343 tablets in healthy subjects after single and multiple oral administration

Conditions

  • Health Volunteer

Interventions

  • RSS0343 tablets ;placeboDrug

    RSS0343 tablets and placebo were given orally as a single dose

  • RSS0343 tablets ;placeboDrug

    RSS0343 tablets and placebo were taken orally multiple times

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. adverse eventsTime frame: The observation lasted until the 61th day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital)

    Shandong, Jinan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.